Recently, the search for novel therapeutic agents against Acanthamoeba species has been focused on the evaluation of natural resources. Among them, marine microorganisms have risen as a source of bioactive compounds with the advantage of the ability to obtain unlimited and constant amounts of the compounds in contrast to other natural sources such as plants. Furthermore, marine actinomycetes have recently been reported as highly rich in bioactive agents including salinosporamides, xiamycines, indolocarbazoles, naphtyridines, phenols, dilactones such as antimycines and macrolides among others. In this study, staurosporine (STS) was isolated from a strain of Streptomyces sanyensis and tested against Acanthamoeba to characterize the therapeutic potential of StS against this protozoan parasite. We have established that STS is active against both stages of the Acanthamoeba life cycle, by the activation of Programmed Cell Death via the mitochondrial pathway of the trophozoite. We have also established that STS has relatively low toxicity towards a macrophage cell line. However, previous studies have highlighted higher toxicity levels induced on other vertebrate cell lines and future research to lower these toxicity issues should be developed.
www.nature.com/scientificreports www.nature.com/scientificreports/ The search for novel compounds against Acanthamoeba species has been lately focused in the evaluation of natural sources presenting anti-Acanthamoeba activity 2, 6, 7 . Among these sources, recent reports have focused on bioactive compounds from marine microorganisms. Mangrove ecosystems in particular, have attracted recently the attention of the scientific community due to the discovery of new drugs with pharmaceutical potential. Mangroves are singular ecosystems, characterized for their high biodiversity and the feasibility to collect samples. More than 200 endophytic fungi and over 2000 actinomycetes have been collected from mangroves, from which a wide array of identified secondary metabolites have displayed a variety of pharmacological properties including antimicrobial, anticancer and antiviral ones among others 8 . Many secondary metabolites have been isolated from marine actynomycetes such as salinosporamides, xiamycines, indolocarbazoles, naphtyridines, phenols, dilactones such as antimycines, macrolides, etc 9, 10 . Among actinomycetes, the genus Streptomyces has gained particular attention in this research field for its richness in bioactive molecules. In particular, the species Streptomyces sanyensis, isolated from a mangrove sediment 11 , was first identified in 2011. Cloning and chemical studies confirmed S. sanyensis as a prolific producer of indolocarbazole (ICZ) alcaloids 12, 13 . The large family of ICZs is characterized by their strong inhibitory effect against many cancer cell lines, platelet aggregation inhibitor, antibacterial, antiviral and neuroprotective properties 14, 15 . Staurosporine (STS, Fig. 1 ), isolated from Streptomyces staurosporeus 14 in 1977, was the first reported ICZ. In addition, STS is a potent affinity inhibitor of protein kinases which blocks the ATP-binding site of the enzimes 16 and it has been demonstrated that STS induces apoptosis by activation of caspase-3 17 in higher eukaryotes. In the present work, we have identified and developed cultures of the strain Streptomyces sanyensis PBLC04, a high-yield producer of STS, and tested the activity of this alkaloid against Acanthamoeba genus with the aim to characterize its therapeutic potential.
Results
culture and molecular identification of Streptomyces sp. PBL04. The strain Streptomyces sp.
PBLC04 showed a high growth rate in 75% seawater-based media, with concave and dry colonies presenting grey aerial mycelia with smooth borders when cultured on plate (Fig. 2) . Microscopic examination revealed pseudomycelia and gram-positive rod-shaped bacteria and supported the identification at genus level. Metabolic production of the strain was detected after 7 days of cultivation at 30 °C, 120 rpm, in a flask containing 75% seawater-based media. DNA sequencing of the obtained PCR fragments of Streptomyces sp. PBLC04, yielded two sequences which showed 100% similarity, for this reason only one was included in the phylogenetic analysis (Genbank Accession Number MK639686). Phylogenetical analyses demonstrated that Streptomyces sp. PBLC04 was included in one clade with bootstrap values 100 NJ/87 ML containing the type sequence 219820 of Streptomyces sanyensis. The pairwise distance for both sequences corresponds to 0.37%. The sequences from Strain PBLC04 compared with the other sequences into this clade corresponded to ≤0.22% (1360 bp base pair compared). The alignments used can be obtained from TreeBASE (http://www.treebase.org/) under accession number S24696.
isolation and characterization of StS from Streptomyces sanyensis PBLC04. Culture of
Streptomyces sanyensis PBLC04 produced STS in great amounts (134 mg), which represents 1.06% of the total content of the biomass extract. The isolation of STS was carried out through three chromatographic steps which involved: gel-filtration on Sephadex LH-20, flash reversed phase C18 with 5 mM ammonium acetate (NH 4 OAc) buffer at pH 6.0 and Si-gel chromatography. Pure STS was separated and crystallized (28.4 mg) as yellow needles from dichloromethane (DCM). C NMR spectral data (see supplementary material) with those previously reported confirmed the structure of STS 19, 20 .
StS eliminates Acanthamoeba trophozoites and cysts at low concentrations and presents low cytotoxicity levels. Staurosporine was able to kill Acanthamoeba trophozoites when incubated in vitro in a dose dependent way. The obtained results using the mentioned colorimetric assay in the material and methods section allowed us to establish IC 50 and IC 90 values of 0.265 ± 0.057 and 1.27 ± 0,007 µg/mL (0.568 ± 0.122 µM and 2.70 ± 0.015 µM) respectively (Fig. 3) . Interestingly, the effects of this compound against the trophozoite stage were seen even at 15 min post incubation with the drug (Fig. 4) .
In the case of cysticidal activity, STS was also active at low concentrations and dose-dependent, being the calculated IC 50 of 0.771 ± 0.008 µg/mL (1.653 ± 0.017 µM) (Fig. 5) .
Moreover, amoebic forms were observed to present dramatic morphological changes such enlargement of the cytoplasm and loss of cellular structure (lack of amoeboid form), again after 15 min of incubation with the compound (Fig. 6) .
Furthermore, toxicity assays against the murine macrophage J774.A1 cell line yielded an CC 50 of 4.076 ± 0.335 (8.737 ± 0.718 µM). Therefore, the toxicity was considered low when compared to the obtained Acanthamoeba inhibitory concentrations of STS.
STS treated amoebae stained positive in the double stain assay. After performance of the double staining protocol, it was observed that STS at both concentrations of IC 50 and IC 90 could induce chromatin condensation. Treated amoebae showed bright-blue stained nuclei even at 24 h after incubation with the compound as shown in Fig. 7 . 
STS increases Reactive Oxygen Species (ROS) levels in Acanthamoeba. STS treated amoebae
caused increased levels of ROS when treated with IC 90 after 24 h of incubation (Fig. 11) .
Discussion
Marine microorganisms, in particular actinobacteria, are responsible for the production of approximately half of the known bioactive secondary metabolites: mainly antibiotics, antitumor agents, and immunosuppressants 21 . The biotechnological potential of marine microorganisms provides the additional advantage in providing a continuous supply of the compound of interest, and to avoid drawbacks such as seasonal occurrence of metabolites, usually linked to other natural sources such as seaweeds or marine invertebrates. In the present study, the strain Streptomyces sanyensis PBLC04, isolated from a mangroove ecosystem in Ecuador, has allowed us the isolation of STS as the major compound when cultured under laboratory conditions. Although STS was first identified and isolated from a strain of S. staurosporeus in 1977 14 , to the best of our knowledge, this is the first time that this molecule is assayed against Acanthamoeba genus.
Regarding the obtained activities against both the trophozoite and cyst stage of Acanthamoeba, it is important to highlight that STS was active at low concentrations when compared to other commonly used drugs against Acanthamoeba such as chlorhexidine (IC 50 = 1.10 ± 0.01 µM) amphotericin B (IC 50 = 65.98 ± 5.91 µM) or PHMB (0.02%) 22, 23 . Moreover, as it was mentioned in the results section, toxicity values when tested against a macrophage cell line were low in comparison to the obtained IC 50 and IC 90 with values 4-fold higher than the STS IC 50 against cysts. However, previous research has shown higher toxicity values after 12 h of exposure to STS [24] [25] [26] . www.nature.com/scientificreports www.nature.com/scientificreports/ Programmed Cell Death (PCD) has been previously reported in our laboratory in Acanthamoeba genus after incubation with compounds such as statins and voriconazole among other molecules 2, 27, 28 . The process of PCD involves multiple changes such as chromatin condensation, cell shrinkage and loss of mitochondrial potential among other phenomena 29 .
In the present study, STS was shown to induce plasma membrane damage, chromatin condensation, collapse of ATP level and mitochondrial membrane potential as well as increased levels of ROS. Since these effects were www.nature.com/scientificreports www.nature.com/scientificreports/ observed even after 15 min of incubation with the compound, it is probable that STS induces damages at the cellular membrane level, entering the cytoplasm without necrotic effects. We argue STS induces apoptosis in Acanthamoeba through the intrinsic pathway since the mitochondrial potential was collapsed even at 24 h (as well as ATP levels) (Fig. 12) . PCD is also indicated by the generation of ROS species and condensation of DNA.
The family of proteins kinases are considered to be the major target of STS. Furthermore, this molecule has demonstrated antiproliferative activity in several human cancer cell lines, inducing apoptosis by activation of caspase-3 30 . These findings in higher eukaryotic cells support the conclusions of our study. The genome of this amoeba 31 is known to be rich in kinase genes and this may be the reason why it is so sensitive. www.nature.com/scientificreports www.nature.com/scientificreports/ conclusion
In conclusion, Streptomyces sanyensis strain PBLC04 produces STS as the major metabolite. Evaluation of the activity of this compound against Acanthamoeba trophozoites and cysts, have shown a high activity of this compound. Moreover, STS-treated amoebae started apoptosis via the mitochondrial pathway. Therefore, STS is presented as a novel, highly active, PCD inducer and low toxic anti-Acanthamoeba compound at least in vitro against the used macrophage cell line which should be exploited for the development of novel therapeutic agents. However, due to the observed toxicity levels in previous studies using other cell lines such as human endothelial cell lines and even the eye, future research should focus on the development of improved delivery of STS in the host tissue which allow to lower toxicity. collection and characterization of Streptomyces sanyensis PBLC04 strain. Streptomyces sanyensis PBLC04 strain was collected in Jambelí mangrove (3°15′792″S, 80°00′739″W -03°17′711″S, 80°01′924″W), Ecuador. The strain is part of the microbial collection of Universidad Técnica Particular de Loja (UTPL, Loja-Ecuador) and the methodology for extraction, culturing and isolation of pure strains from mangrove sediments was performed as described by Cartuche L. et al. 32 .
DNA isolation, PCR and phylogenetic analysis. The DNA was extracted with PureLink Genomic DNA Mini Kit (Invitrogen) for gram-positive bacteria, according to manufacturing specifications. Partial 16S rDNA region was amplified by using the universal primers for bacteria: 27F (5′-AGAGTTTGATCMTGGCTCAG-3′) and 1492R (I) (5′-GGTTACCTTGTTACGACTT-3′) 33 . The PCR protocol used was: initial denaturation at 98 °C for 30 s, followed by 30 cycles of 98 °C denaturation for 10 s, annealing at 60 °C for 20 s, extension at 72 °C for 30 s and a final extension at 72 °C for 10 min. The volume of reaction was 20 μL, 1 ρmol each primer and 1U of Finnzymes' Phusion High-Fidelity DNA Polymerase of final concentration. PCR products were visualized on 1% (w/v) agarose gels stained with 5% (v/v) GelRed (Biotium, Hayward, USA). The purified products were sequenced at Macrogen (Seoul -Republic of Korea).
The sequence chromatograms were verified using the software Codon Code Aligner 5. www.nature.com/scientificreports www.nature.com/scientificreports/ sequences were aligned using the G-INS-i strategy as implemented in MAFFT V7 34 . Three phylogenetic trees were built using a Neighbour-Joining (NJ) analysis with BIONJ modification of the NJ algorithm 35 , Maximum Likelihood (ML) based on 1000 bootstrap replications 36 and GTRMIX as DNA substitution model 37 implemented in MEGA v.7 software 38 .
Fermentation conditions and culture extraction. Streptomyces sanyensis PBLC04 strain was cultured in 30 L of a modified seawater-based medium (A1) consisting of 75% seawater containing 10 g starch, 4 g yeast extract, 2 g proteose peptone, 1 g calcium carbonate, supplemented with 5 mL/L of a solution of potassium bromide (67 mM) and ferric sulfate (20 mM) 39 . Fernbach flasks with 1 L each were kept at 30 °C and mixed in an orbital shaker at 200 rpm for 7 days.
Cultures of S. sanyensis PBLC04 were centrifuged at 5000 rpm for 10 min to separate supernatant from cell biomass. Amberlite XAD7-HP resin (20 g/L) were added to the supernatant and stirred for 3 h to adsorb the excreted metabolites. After filtration, both the resin and the biomass pellet were separately macerated with a mixture of MeOH:AcOEt:Acetone (2:7:3) for 12 h at 120 rpm. Then, the two resulting extracts were filtered and dried at reduced pressure at 30 °C in a rotary evaporator.
Isolation of STS from biomass extract. The salt-free biomass extract (12.6 g) was fractionated by size-exclusion chromatography on Sephadex-LH-20 with methanol as eluent to yield 10 fractions that were finally gathered in four final fractions according to TLC and In vitro effect against the trophozoite stage of acanthamoeba. The anti-Acanthamoeba activities of the tested compound was determined by the Alamar Blue assay as previously described 2, 27 . Briefly, Acanthamoeba strains were seeded in duplicate on a 96-well microtiter plate with 50 μL from a stock solution of 10 4 cells/mL. Amoebae were allowed to adhere for 15 min and 50 μL of serial dilution series of the tested compound was added. Finally, the Alamar Blue Assay Reagent (Bioresource, Europe, Nivelles, Belgium) was added into each well at an amount equal to 10% of the medium volume. The plates were then incubated for 96 h at 28 °C with a slight agitation and the emitted fluorescence was examined with an Enspire microplate reader (PerkinElmer, Massachusetts, USA) at 570/585 nm.
In vitro effect against the cyst stage of acanthamoeba. The cysticidal activity of STS was determined by the Alamar Blue assay and confirmed visually by inverted microscopy. Cysts of A. castellaniii Neff were prepared as previously described 40 . Briefly, trophozoites were transferred from PYG medium based cultures (trophozoite medium) to Neff´s encystment medium (NEM; 0.1 M KCl, 8 mM MgSO 4 ·7H 2 O, 0.4 mM CaCl 2 ·2H 2 O, 1 mM NaHCO 3 , 20 mM ammediol [2-amino-2-methyl-1,3-propanediol; Sigma Aldrich Chemistry Ltd., Madrid, Spain], pH 8.8, at 25 °C) and were cultured in this medium with gently shaking for a week in order to obtain mature cysts. After that, mature cysts were harvested and washed twice using PYG medium.
A serial dilution of the tested molecules was made in PYG. The in vitro susceptibility assay was performed in sterile 96-well microtiter plates (Corning ™ ). To these wells, containing 50 µL of drug dilutions, 5·10
4 mature cysts of Acanthamoeba/mL were added. After 7 days of incubation with the drugs, the plate was centrifuged at 3000 rpm for 10 min. The supernatant was removed and replaced with 100 µL of fresh medium PYG in each well. Finally, 10 μL of the Alamar Blue Assay Reagent (Biosource, Europe, Nivelles, Belgium) was placed into each well, and the plates were then incubated for 144 h at 28 °C and the emitted fluorescence was periodically examined with an Enspire microplate reader (PerkinElmer, Massachusetts, USA) at 570/585 nm.
Cytotoxicity assays. Cytotoxicity of STS was evaluated after 24 h incubation of murine macrophage J774.A1 cell line (ATCC # TIB-67) with different concentration of the tested compound at 37 °C in a 5% CO 2 humidified incubator. The viability of the macrophages was determined with the Alamar Blue assay as previously described 2 . Double-stain assay for programmed cell death determination. A double-stain apoptosis detection kit (Hoechst 33342/PI) (GenScript, Piscataway, NJ, USA) and an EVOS FL Cell Imaging System AMF4300, Life Technologies, USA were used. The experiment was carried out by following the manufacturer's recommendations, and 10 5 cells/ well were incubated in a 24-well plate for 24 h with the previously calculated IC 90 . The double-staining pattern allows the identification of three groups in a cellular population: live cells will show only a low level of fluorescence, cells undergoing PCD will show a higher level of blue fluorescence (as chromatin condenses), and dead cells will show low-blue and high-red fluorescence (as the Propidium Iodide stain enters the nucleus).
Intracellular ROS production using CellROX deep red staining. The generation of intracellular ROS was detected using the CellROX Deep Red fluorescent probe (Invitrogen). The cells were treated with IC 90 of STS for 24 h and exposed to CellROX Deep Red (5 μM, 30 min) at 26 °C in the dark. Cells were observed in a Leica TSC SPE-confocal microscope equipped with inverted optics at λ exc = 633 and λ em = 519 nm.
Analysis of mitochondrial membrane potential. The collapse of an electrochemical gradient across the mitochondrial membrane during apoptosis was detected with the JC-1 mitochondrial membrane potential detection kit 
